PharmaShots | Incisive News in 3 Shots

Subscribe Now

Livmarli

Mirum’s Livmarli (maralixibat) Receives the Label Expansion Approval from the US FDA for Alagille Syndrome in Infants Aged ≥3 Months

Mirum’s Livmarli (maralixibat) Receives the Label Expansion Approval from the US FDA for Alagille Syndrome in Infants Aged ≥3 Mont...

March 15, 2023

Celltrion's Regdanvimab Receives the EC's Approval for the Treatment of COVID-19

Celltrion's Regdanvimab Receives the EC's Approval for the Treatment of COVID-19

November 16, 2021

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us